Going Back to School
Often started by the academic inventors or their laboratory acolytes, biotechs offer equity participations (to universities and researchers) as well as focused attention to their inventions. As large companies have steadily invested in and improved their own discovery operations, in particular going further into the basic research which is the stuff of academic labs, they find themselves positioned to exploit university research in a more focused way-and thus are more willing than ever to do universi
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker.
Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.